MedPath

Efficacy of dual parenteral artemisinin-based combination therapy for cerebral malaria in a randomized control trial in Nigerian children.

Not Applicable
Not yet recruiting
Conditions
Malaria
Registration Number
PACTR202102893629864
Lead Sponsor
Alao Michael and Co Authors
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
359
Inclusion Criteria

1.Children between the ages of 6 months to 17 years as at the last birthday
2.Children with unarousable coma lasting more than 30 minutes in the presence of demonstratable peripheral asexual P. falciparum parasitemia.
3.Children who develop deterioration in their level of consciousness after admission and demonstrate asexual Plasmodium falciparum in the peripheral blood.

Exclusion Criteria

1.Children with positive biochemical and/or microbiological CSF result consistent with a diagnosis of meningitis
2.Children who have intracranial infections or intracranial space-occupying lesions
3.Children with previous neurological deficit either focal or global

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.